Related Experiment Video
Updated: Jul 18, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
Mykhailo Buchynskyi1, Valentyn Oksenych2, Iryna Kamyshna3
1Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, 46001 Ternopil, Ukraine.
Abstract:
Metabolic-associated fatty liver disease (MAFLD) and its potential impact on the severity of COVID-19 have gained significant attention during the pandemic. This review aimed to explore the genetic determinants associated with MAFLD, previously recognized as non-alcoholic fatty liver disease (NAFLD), and their potential influence on COVID-19 outcomes. Various genetic polymorphisms, including PNPLA3 (rs738409), GCKR (rs780094), TM6SF2 (rs58542926), and LYPLAL1 (rs12137855), have been investigated in relation to MAFLD susceptibility and progression. Genome-wide association studies and meta-analyses have revealed associations between these genetic variants and MAFLD risk, as well as their effects on lipid metabolism, glucose regulation, and liver function. Furthermore, emerging evidence suggests a possible connection between these MAFLD-associated polymorphisms and the severity of COVID-19. Studies exploring the association between indicated genetic variants and COVID-19 outcomes have shown conflicting results. Some studies observed a potential protective effect of certain variants against severe COVID-19, while others reported no significant associations. This review highlights the importance of understanding the genetic determinants of MAFLD and its potential implications for COVID-19 outcomes. Further research is needed to elucidate the precise mechanisms linking these genetic variants to disease severity and to develop gene profiling tools for the early prediction of COVID-19 outcomes. If confirmed as determinants of disease severity, these genetic polymorphisms could aid in the identification of high-risk individuals and in improving the management of COVID-19.
Insights
Genetic factors influence metabolic-associated fatty liver disease (MAFLD) and COVID-19 severity. Specific gene variants linked to MAFLD show mixed associations with severe COVID-19 outcomes, requiring further research.
Area of Science:
- Genetics
- Hepatology
- Infectious Diseases
Background:
- Metabolic-associated fatty liver disease (MAFLD), formerly NAFLD, and its link to COVID-19 severity are significant research areas.
- Genetic polymorphisms are known to influence MAFLD susceptibility and progression.
Purpose of the Study:
- To review genetic determinants of MAFLD and their potential impact on COVID-19 outcomes.
- To explore specific gene variants (PNPLA3, GCKR, TM6SF2, LYPLAL1) associated with MAFLD.
Main Methods:
- Literature review of genome-wide association studies and meta-analyses.
- Examination of studies investigating genetic variants in MAFLD and COVID-19.
Main Results:
- Several genetic polymorphisms (PNPLA3, GCKR, TM6SF2, LYPLAL1) are associated with MAFLD risk and metabolic dysfunction.
- The association between these MAFLD-related genetic variants and COVID-19 severity is currently inconclusive, with conflicting findings.
Conclusions:
- Understanding MAFLD genetic determinants is crucial for assessing COVID-19 outcomes.
- Further research is needed to clarify the role of these genetic variants in disease severity and for potential risk stratification in COVID-19 patients.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genomics